References:
- Martín S, Pérez A, Aldecoa C . Sepsis and Immunosenescence in the
Elderly Patient: A Review. Front Med (Lausanne). 2017; 4:20.
- Perner A, Rhodes A, Venkatesh B, Angus DC, Martin-Loeches I, Preiser
JC, Vincent JL, Marshall J, Reinhart K, Joannidis M, Opal SM. Sepsis:
frontiers in supportive care, organisation and research. Intensive
Care Med. 2017 Apr; 43(4):496-5.
- Sorensen TI, Nielsen GG, Andersen PK, et al. Genetic and environmental
in fluences on premature death in adult adoptees. N Engl J Med 1988;
318:727–732
- Ludwig KR, Hummon AB. Mass spectrometry for the discovery of
biomarkers of sepsis. Mol Biosyst. 2017;13:648–64.
- Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent
JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.
- Liu R, Mo YY, Wang HL, Tan Y, Wen XJ, Deng MJ, Yan H, Li L. The
relationship between toll like receptor 4 gene rs4986790 and rs4986791
polymorphisms and sepsis susceptibility: a meta-analysis. Sci Rep.
2016;6:38947.
- Shi Q, Mu X, Hong L, Zheng S. SERPINE1 rs1799768 polymorphism
contributes to sepsis risk and mortality. J Renin Angiotensin
Aldosterone Syst. 2015;16:1218–24.
- Qiao YC, Chen YL, Pan YH, Tian F, Xu Y, Zhang XX, Zhao HL. The change
of serum tumor necrosis factor alpha in patients with type 1 diabetes
mellitus: a systematic review and meta-analysis. PLoS One.
2017;12:e0176157.
- El-Tahan RR, Ghoneim AM, El-Mashad N. TNF-alpha gene polymorphisms and
expression. Springerplus. 2016;5:1508.
- Lv B, Huang J, Yuan H, Yan W, Hu G. Tumor necrosis factor-alpha as a
diagnostic marker for neonatal sepsis: a meta-analysis.
2014;2014:471463.
- Patel HJ, Patel BM. TNF-alpha and cancer cachexia: molecular insights
and clinical implications. Life Sci. 2017;170:56–63.
- Kali A. TNFerade, an innovative cancer immunotherapeutic. Indian J
Pharmacol. 2015;47:479–83.
- Flori L, Delahaye NF, Iraqi FA, Hernandez-Valladares M, Fumoux F,
Rihet P. TNF as a malaria candidate gene: polymorphism-screening and
family-based association analysis of mild malaria attack and
parasitemia in Burkina Faso. Genes Immun. 2005;6:472–80.
- Gupta DL, Nagar PK, Kamal VK, Bhoi S, Rao DN. Clinical relevance of
single nucleotide polymorphisms within the 13 cytokine genes in North
Indian trauma hemorrhagic shock patients. Scand J Trauma Resusc Emerg
Med. 2015;23:96.
- Nakada TA, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, Watanabe
E, Abe R, Hatano M, Tokuhisa T. Influence of toll-like receptor 4,
CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on
clinical outcome in Japanese critically ill patients. J Surg Res.
2005;129:322–8.
- Song Z, Song Y, Yin J, Shen Y, Yao C, Sun Z, Jiang J, Zhu D, Zhang Y,
Shen Q, Gao L, Tong C, Bai C. Genetic variation in the TNF gene is
associated with susceptibility to severe sepsis, but not with
mortality. PLoS One. 2012;7:e46113.
- 16. Sipahi T, Pocan H, Akar N. Effect of various genetic polymorphisms
on the incidence and outcome of severe sepsis. Clin Appl Thromb
Hemost. 2006;12:47–54.]
- 17. Schueller AC, Heep A, Kattner E, Kroll M, Wisbauer M, Sander J,
Bartmann P, Stuber F. Prevalence of two tumor necrosis factor gene
polymorphisms in premature infants with early onset sepsis. Biol
Neonate. 2006;90:229–32.
- 18. Treszl A, Kocsis I, Szathmari M, Schuler A, Heninger E, Tulassay
T, Vasarhelyi B. Genetic variants of TNF-[FC12]a, IL-1beta, IL-4
receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors
for sepsis in low-birth-weight infants. Biol Neonate. 2003;83:241–5.
- Wilson AG, di Giovine FS, Blakemore AI, et al: Single base
polymorphism in the human tumour necrosis factor alpha (TNF alpha)
gene detectable by NcoI restriction of PCR product. Hum Mol Genet
1992; 1:353.
- Hajeer AH, Hutchinson IV: Influence of TNF alpha gene polymorphisms on
TNF alpha production and disease. Hum Immunol. 2001; 62:1191–1199
- Debets JM, Kampmeijer R, van der Linden MP, et al: Plasma tumor
necrosis factor and mortality in critically ill septic patients. Crit
Care Med 1989; 17:489–494
- Waage A, Halstensen A, Espevik T: Association between tumour necrosis
factor in serum and fatal outcome in patients with meningococcal
disease. Lancet 1987; 1:355–357
- Papathanassoglou ED, Giannakopoulou MD, Bozas E: Genomic variations
and susceptibility to sepsis. AACN Adv Crit Care 2006; 17:394–422
- Teuffel O, Ethier MC, Beyene J, Sung L. Association between tumor
necrosis factor-alpha promoter -308 A/G polymorphism and
susceptibility to sepsis and sepsis mortality: a systematic review and
meta-analysis. Crit Care Med. 2010;38:276–82.
- Zhang M, Zhao Y, Liu Q. Tumor necrosis factor-alpha -308G/A and
-238G/A polymorphisms are associated with increased risks of sepsis:
evidence from an updated meta-analysis. APMIS. 2017
- Tian H, Wei D, He X. Relationships of TNF-α gene polymorphism with
susceptibility to sepsis and its infections degrees. Shandong Med J.
2015; 55:17-9
- Fu Y, Chen Y, Bai N, Liu R, Li D. Correlation of TNF-alpha gene
polymorphisms with sepsis susceptibility. Int J Clin Exp Pathol. 2016;
9:2335-9
- Sole-Violan J, de Castro F, Garcia-Laorden MI, Blanquer J, Aspa J,
Borderias L, Briones ML, Rajas O, Carrondo IM, Marcos-Ramos JA, Ferrer
Aguero JM, GarciaSaavedra A, Fiuza MD, et al. Genetic variability in
the severity and outcome of community-acquired pneumonia.
- Respir Med. 2010; 104:440-7.
- Mira JP, Cariou A, Grall F, et al: Association of TNF2, a TNF-alpha
promoter polymorphism, with septic shock susceptibility and mortality:
A multicenter study. JAMA 1999; 282:561–568
- Gordon AC, Lagan AL, Aganna E, et al: TNF and TNFR polymorphisms in
severe sepsis
- and septic shock: A prospective multicentre study. Genes Immun 2004;
5:631–640
- Sipahi T, Pocan H, Akar N. Effect of various genetic polymorphisms on
the incidence and outcome of severe sepsis. Clin Appl Thromb Hemost.
2006;12:47–54.
- Allam G, Alsulaimani AA, Alzaharani AK, Nasr A. Neonatal infections in
Saudi Arabia: Association with cytokine gene polymorphisms. Cent Eur J
Immunol. 2015;40:68–77.
- Duan ZX, Gu W, Zhang LY, Jiang DP, Zhou J, Du DY, Zen L, Chen KH, Liu
Q, Jiang JX. Tumor necrosis factor alpha gene polymorphism is
associated with the outcome of trauma patients in Chinese Han
population. J Trauma. 2011;70:954–958.
- Paskulin DD, Fallavena PR, Paludo FJ, Borges TJ, Picanço JB, Dias FS,
Alho CS. TNF −308G > a promoter polymorphism (rs1800629)
and outcome from critical illness. Braz J Infect Dis.
2011;15:231–238.
- Jaber BL, Rao M, Guo D, Balakrishnan VS, Perianayagam MC, Freeman RB,
Pereira BJ. Cytokine gene promoter polymorphisms and mortality in
acute renal failure. Cytokine. 2004;25:212–219.
- McDaniel DO, Hamilton J, Brock M, May W, Calcote L, Tee LY, Vick L,
Newman DB, Vick K, Harrison S, Timberlake G, Toevs C. Molecular
analysis of inflammatory markers in trauma patients at risk of
postinjury complications. J Trauma. 2007;63:147–157. discussion
157–8.
- Garnacho-Montero J, Aldabo-Pallas T, Garnacho-Montero C, Cayuela A,
Jiménez R, Barroso S, Ortiz-Leyba C. Timing of adequate antibiotic
therapy is a greater determinant of outcome than are TNF and IL-10
polymorphisms in patients with sepsis. Crit Care. 2006;10:R111.
- Kothari N, Bogra J, Abbas H, Kohli M, Malik A, Kothari D, Srivastava
S, Singh PK. Tumor necrosis factor gene polymorphism results in high
TNF level in sepsis and septic shock. Cytokine. 2013;61:676–681.
- Susantitaphong P, Perianayagam MC, Tighiouart H, Liangos O, Bonventre
JV, Jaber BL. Tumor necrosis factor alpha promoter polymorphism and
severity of acute kidney injury. Nephron Clin Pract. 2013;123:67–73.
- Schaaf BM, Boehmke F, Esnaashari H, Seitzer U, Kothe H, Maass M, Zabel
P, Dalhoff K. Pneumococcal septic shock is associated with the
interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care
Med. 2003;168:476–480.
- Schueller AC, Heep A, Kattner E, Kroll M, Wisbauer M, Sander J,
Bartmann P, Stuber F. Prevalence of two tumor necrosis factor gene
polymorphisms in premature infants with early onset sepsis. Biol
Neonate. 2006;90:229–232.
- Balding J, Healy CM, Livingstone WJ, White B, Mynett-Johnson L,
Cafferkey M, Smith OP. Genomic polymorphic profiles in an Irish
population with meningococcaemia: is it possible to predict severity
and outcome of disease? Genes Immun. 2003;4:533–540.
- Majetschak M, Obertacke U, Schade FU, Bardenheuer M, Voggenreiter G,
Bloemeke B, Heesen M. Tumor necrosis factor gene polymorphisms,
leukocyte function, and sepsis susceptibility in blunt trauma
patients. Clin Diagn Lab Immunol. 2002;9:1205–1211.